BD launches industry-first bioabsorbable mesh for umbilical hernia repair

BD (Becton, Dickinson and Company) announced FDA 510(k) clearance and commercial launch of the Phasix ST Umbilical Hernia Patch, the first fully absorbable mesh specifically designed for umbilical hernias. Composed of the bioabsorbable polymer Poly-4-hydroxybutyrate (P4HB) and incorporating Sepra Technology, the patch mimics the technique and function of permanent mesh while offering a fully absorbable alternative.

Surgeons can deploy the new patch using the same method as traditional permanent mesh, making it easier to adopt in existing surgical workflows. The design enhances placement and fixation through a pocket and strap mechanism, modeled after the widely used Ventralex ST Hernia Patch.

Recent survey data cited by BD shows that 60% of patients prefer non-permanent mesh, and over 70% of surgeons are willing to consider patient preferences. The new product extends BD’s Phasix Mesh portfolio, which has over 385,000 implants globally and is backed by more than 85 clinical publications.

BD emphasized its commitment to innovation in tissue repair and the continued development of advanced biomaterials for improved patient outcomes. The Phasix ST Umbilical Patch is available in three sizes to support a range of hernia repair needs.